Home > Boards > US Listed > Biotechs > Adamis Pharmaceuticals Corporation (ADMP)

Welcome back nurse! Missed a good scoop opportunity

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (4) | Next 10 | Previous | Next
BigT82 Member Profile
 
Followed By 10
Posts 2,609
Boards Moderated 2
Alias Born 12/24/14
160x600 placeholder
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 6/14/2021 10:32:44 AM
Adamis Files Definitive Proxy Statement and Sends Letter to Stockholders Business Wire - 6/14/2021 9:00:00 AM
Proxy Statment - Contested Solicitations (definitive) (defc14a) Edgar (US Regulatory) - 6/14/2021 6:03:38 AM
Adamis begins clinical trial start-up activities for COVID drug; shares rise 5% Seeking Alpha - 6/11/2021 8:33:04 AM
Adamis Provides Update on Clinical Trial Start-Up Progress for Tempol in the Treatment of COVID-19 GlobeNewswire Inc. - 6/11/2021 7:30:00 AM
Adamis Pharma soars 18% after FDA accepts Zimhi application for review Seeking Alpha - 6/9/2021 7:46:12 AM
Adamis Provides Update on ZIMHI™ GlobeNewswire Inc. - 6/9/2021 7:30:00 AM
Adamis Highlights National Institute of Health Study Identifying Tempol as a Potential Antiviral Drug for COVID-19 GlobeNewswire Inc. - 6/7/2021 7:30:00 AM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 6/2/2021 5:37:32 PM
Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a) Edgar (US Regulatory) - 6/2/2021 8:20:43 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/1/2021 4:37:06 PM
Adamis Pharmaceuticals Provides Business Update GlobeNewswire Inc. - 6/1/2021 7:30:00 AM
Adamis pharmaceuticals gets deficiency letter from NASDAQ Seeking Alpha - 5/28/2021 4:09:47 PM
Adamis Pharmaceuticals Announces Receipt of Deficiency Letter from NASDAQ GlobeNewswire Inc. - 5/28/2021 4:04:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/27/2021 5:12:17 PM
Amended Notification That Quarterly Report Will Be Submitted Late (nt 10-q/a) Edgar (US Regulatory) - 5/24/2021 5:22:16 PM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) Edgar (US Regulatory) - 5/17/2021 4:17:20 PM
Adamis Pharmaceuticals Provides Update on First Quarter 2021 Financial Results Conference Call GlobeNewswire Inc. - 5/17/2021 4:05:00 PM
Adamis resubmits ZIMHI opioid overdose treatment NDA Seeking Alpha - 5/17/2021 7:45:45 AM
Adamis Pharmaceuticals Resubmits ZIMHI New Drug Application to FDA for the Treatment of Opioid Overdose GlobeNewswire Inc. - 5/17/2021 7:30:00 AM
Adamis Pharmaceuticals Schedules First Quarter 2021 Financial Results Conference Call and Business Update GlobeNewswire Inc. - 5/12/2021 7:30:00 AM
Amended Annual Report (10-k/a) Edgar (US Regulatory) - 4/30/2021 4:51:44 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/15/2021 5:04:55 PM
Annual Report (10-k) Edgar (US Regulatory) - 4/15/2021 5:04:18 PM
Adamis Pharmaceuticals misses on revenue Seeking Alpha - 4/15/2021 4:55:17 PM
BigT82   Friday, 05/07/21 11:22:02 AM
Re: OR Nurse post# 2531
Post # of 2756 
Welcome back nurse! Missed a good scoop opportunity in the mid 70s yesterday and this morning but all good. Your basis is lower than mine! I’m currently at .98 but with almost 20x your share count…

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (4) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences